alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › tau-pathology

tau-pathology

6 studies tagged tau-pathology, dated 2022-06-30 to 2025-09-05. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer's Disease 2025-09-05
  2. APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-β 2025-07-01
  3. Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis 2024-04-12

Studies

6 studies carry this tag.

Date range

2022 to 2025

Top journals

  • Alzheimer's research & therapy 1
  • Brain : a journal of neurology 1
  • Frontiers in aging neuroscience 1
  • Molecular psychiatry 1
  • Nature aging 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Nature communications 2025-09-05 Biomarkers

    The distribution of tau pathology in Alzheimer's disease (AD) shows remarkable inter-individual heterogeneity, including hemispheric asymmetry.

  2. APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-β

    ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Brain : a journal of neurology 2025-07-01 Biomarkers

    Although APOE4 is strongly associated with amyloid-β (Aβ), its relationship with tau accumulation is less understood.

  3. Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 83 out of 100. Alzheimer's research & therapy 2024-04-12 Biomarkers

    Identifying Aβ-positive individuals, irrespective of the measurement technique employed (CSF or PET), enables the detection of the most at-risk population before disease onset, or at least at a mild stage.

  4. Tau pathology is associated with synaptic density and longitudinal synaptic loss in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Molecular psychiatry 2024-04-08 Biomarkers

    The associations of synaptic loss with amyloid-β (Aβ) and tau pathology measured by positron emission tomography (PET) and plasma analysis in Alzheimer's disease (AD) patients are unknown.

  5. APOEε4 potentiates amyloid β effects on longitudinal tau pathology

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Nature aging 2023-09-25 Biomarkers

    The mechanisms by which the apolipoprotein E ε4 (APOEε4) allele influences the pathophysiological progression of Alzheimer's disease (AD) are poorly understood.

  6. Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer's Disease Continuum

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Frontiers in aging neuroscience 2022-06-30 Biomarkers

    Baseline CSF Aβ42/Aβ40 ratio was decreased in MCI and AD compared to CN, while CSF p-tau181 and t-tau increased.

All topic tags with their study counts